414 results
8-K
EX-99.1
BIIB
Biogen Inc
24 Apr 24
First quarter revenue $2.3 billion; GAAP diluted EPS $2.70; Non-GAAP diluted EPS $3.67
7:02am
and qualitative aspects of the item, including (i) its size and nature, (ii) whether or not it relates to our ongoing business operations and (iii) whether
8-K
EX-99.1
tm8u44 qn
13 Feb 24
Biogen reports fourth quarter and full year 2023 results and expects return to Non-GAAP EPS growth in 2024
7:07am
8-K
EX-3.2
4f5ks1ewhy6 c6da
12 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:36pm
8-K
EX-3.1
a7btnjre gxtejyjt
12 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:36pm
8-K
EX-99.1
061v9h2
8 Nov 23
Biogen reports third quarter 2023 results and updates full year 2023 guidance
7:02am
8-K
EX-10.1
d4kb9527vsqdsm2fvpu0
1 Sep 23
Entry into a Material Definitive Agreement
4:36pm
DEFA14A
tu4f7rdux9mm fvr
31 Jul 23
Additional proxy soliciting materials
7:02am
8-K
EX-2.1
mn9pferjr0zhs08fw3oe
31 Jul 23
Entry into a Material Definitive Agreement
7:00am
8-K
EX-3.1
a22srj2el 5pl0g71xn
31 Jul 23
Entry into a Material Definitive Agreement
7:00am
8-K
EX-10.1
e4km7m kv77gpjirf7
31 Jul 23
Entry into a Material Definitive Agreement
7:00am
8-K
EX-10.2
rdcursezj ky16x
31 Jul 23
Entry into a Material Definitive Agreement
7:00am
8-K
EX-10.3
rnjq9l035ng6x 8e
31 Jul 23
Entry into a Material Definitive Agreement
7:00am